v3.26.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Measurements [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value

The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2026 and 2025, there were no transfers between Levels 2 and 3.

    March 31, 2026
    Total   Level 1   Level 2   Level 3
Assets:                
Recurring fair value measurements:                                
Cash equivalents   $ 258,450     $ 258,450     $     $  
Financial instruments owned, at fair value:                                
ETFs     42,207       42,207              
Pass-through GSEs     5,837             5,837        
Other assets—seed capital (WisdomTree Digital Funds):                                
U.S. treasuries     4,733             4,733        
Equities     10,078       10,078              
Fixed income     2,382       1,016       1,366        
Total   $ 323,687     $ 311,751     $ 11,936     $  
Liabilities:                                
Recurring fair value measurements:                                
Contingent consideration   $ 14,406     $     $     $ 14,406  

    December 31, 2025
    Total   Level 1   Level 2   Level 3
Assets:                                
Recurring fair value measurements:                                
Cash equivalents   $ 161,063     $ 161,063     $     $  
Financial instruments owned, at fair value:                                
ETFs     81,737       81,737              
Pass-through GSEs     6,053             6,053        
Other assets—seed capital (WisdomTree Digital Funds):                                
U.S. treasuries     5,402             5,402        
Equities     11,824       11,824              
Fixed income     2,101       1,138       963        
Total   $ 268,180     $ 255,762     $ 12,418     $  
Non-recurring fair value measurements:                                
Fnality International Limited—Series B-1 Preference Shares(1)   $ 8,035     $     $     $ 8,035  
Liabilities:                                
Recurring fair value measurements:                                
Contingent consideration   $ 11,844     $     $     $ 11,844  

_____________________________

(1)  Fair value determined on September 10, 2025. Not included in the table above are prospective changes in value due to fluctuations in the British pound to U.S. dollar exchange rate.
Schedule of Instruments

These instruments consist of the following:

    Three Months Ended
   

March 31,
2026

 

March 31,
2025

Other Investments:                
Beginning balance   $     $ 687  
Net unrealized gains(1)           68  
Ending balance   $     $ 755  
Contingent Consideration:                
Beginning balance   $ 11,844     $  
Remeasurement(2)     2,562        
Ending balance   $ 14,406        

_____________________________

(1) Recorded in impairments and other losses, net in the Consolidated Statements of Operations.
(2) Recorded in remeasurement of contingent consideration in the Consolidated Statements of Operations.